Helminth-Based Product and the Microbiome of Mice with Lupus

ABSTRACT The hygiene hypothesis claims that the lack of exposure to microorganisms in developed countries correlates with a rise in the incidence of autoimmune diseases. It was also found that helminths are able to modulate the immune response in hosts in order to survive. Consequently, several succ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hadar Neuman, Hadar Mor, Tomer Bashi, Or Givol, Abdulla Watad, Asaf Shemer, Alexander Volkov, Iris Barshack, Mati Fridkin, Miri Blank, Yehuda Shoenfeld, Omry Koren
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://doaj.org/article/d59cf3085af04671b14056e5a2b00d22
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d59cf3085af04671b14056e5a2b00d22
record_format dspace
spelling oai:doaj.org-article:d59cf3085af04671b14056e5a2b00d222021-12-02T18:15:45ZHelminth-Based Product and the Microbiome of Mice with Lupus10.1128/mSystems.00160-182379-5077https://doaj.org/article/d59cf3085af04671b14056e5a2b00d222019-02-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSystems.00160-18https://doaj.org/toc/2379-5077ABSTRACT The hygiene hypothesis claims that the lack of exposure to microorganisms in developed countries correlates with a rise in the incidence of autoimmune diseases. It was also found that helminths are able to modulate the immune response in hosts in order to survive. Consequently, several successful trials using helminths as a treatment for autoimmune patients have been reported. The helminth derivative, phosphorylcholine (PC), was discovered as an immunomodulatory molecule. We have recently shown in a murine model that when a conjugate of tuftsin and PC, termed TPC, is prophylactically administered before the onset of glomerulonephritis, it attenuates the development of systemic lupus erythematosus (SLE). The current study aimed to examine the TPC effect on the gut microbiome in a mouse model of lupus. TPC treatment altered the gut composition in the mice with active lupus, in correlation with a significant decrease in glomerulonephritis, followed by an increased level of anti-inflammatory interleukin 10 (IL-10), decreased levels of proinflammatory mediators, and expansion of the T regulatory cell population. Importantly, we found that TPC treatment altered the mouse gut microbiome composition, in correlation with a significant decrease in protein secretion and improved disease parameters. The major effects of TPC treatment on the gut microbiome included decreased abundances of Akkermansia and increased abundance of several genera, including Turicibacter, Bifidobacterium, unclassified Mogibacteriaceae, unclassified Clostridiaceae, Adlercreutzia, Allobaculum, and Anaeroplasma. Overall, our results associate microbial changes with the immunomodulation of glomerulonephritis in mice with lupus. IMPORTANCE Recently, several papers referred to the association of different bacteria with lupus in mice and humans. This is the first report to demonstrate the effect of a compound derived from helminths on the induction of remission in mice with lupus and its association with a bacterial change. We show that several genera, including Akkermansia, are associated with clinical and serological parameters of lupus, while other genera, including butyrate-producing bacteria, are associated with amelioration of disease following tuftsin and phosphorylcholine treatment.Hadar NeumanHadar MorTomer BashiOr GivolAbdulla WatadAsaf ShemerAlexander VolkovIris BarshackMati FridkinMiri BlankYehuda ShoenfeldOmry KorenAmerican Society for MicrobiologyarticlehelminthlupusmicrobiomeMicrobiologyQR1-502ENmSystems, Vol 4, Iss 1 (2019)
institution DOAJ
collection DOAJ
language EN
topic helminth
lupus
microbiome
Microbiology
QR1-502
spellingShingle helminth
lupus
microbiome
Microbiology
QR1-502
Hadar Neuman
Hadar Mor
Tomer Bashi
Or Givol
Abdulla Watad
Asaf Shemer
Alexander Volkov
Iris Barshack
Mati Fridkin
Miri Blank
Yehuda Shoenfeld
Omry Koren
Helminth-Based Product and the Microbiome of Mice with Lupus
description ABSTRACT The hygiene hypothesis claims that the lack of exposure to microorganisms in developed countries correlates with a rise in the incidence of autoimmune diseases. It was also found that helminths are able to modulate the immune response in hosts in order to survive. Consequently, several successful trials using helminths as a treatment for autoimmune patients have been reported. The helminth derivative, phosphorylcholine (PC), was discovered as an immunomodulatory molecule. We have recently shown in a murine model that when a conjugate of tuftsin and PC, termed TPC, is prophylactically administered before the onset of glomerulonephritis, it attenuates the development of systemic lupus erythematosus (SLE). The current study aimed to examine the TPC effect on the gut microbiome in a mouse model of lupus. TPC treatment altered the gut composition in the mice with active lupus, in correlation with a significant decrease in glomerulonephritis, followed by an increased level of anti-inflammatory interleukin 10 (IL-10), decreased levels of proinflammatory mediators, and expansion of the T regulatory cell population. Importantly, we found that TPC treatment altered the mouse gut microbiome composition, in correlation with a significant decrease in protein secretion and improved disease parameters. The major effects of TPC treatment on the gut microbiome included decreased abundances of Akkermansia and increased abundance of several genera, including Turicibacter, Bifidobacterium, unclassified Mogibacteriaceae, unclassified Clostridiaceae, Adlercreutzia, Allobaculum, and Anaeroplasma. Overall, our results associate microbial changes with the immunomodulation of glomerulonephritis in mice with lupus. IMPORTANCE Recently, several papers referred to the association of different bacteria with lupus in mice and humans. This is the first report to demonstrate the effect of a compound derived from helminths on the induction of remission in mice with lupus and its association with a bacterial change. We show that several genera, including Akkermansia, are associated with clinical and serological parameters of lupus, while other genera, including butyrate-producing bacteria, are associated with amelioration of disease following tuftsin and phosphorylcholine treatment.
format article
author Hadar Neuman
Hadar Mor
Tomer Bashi
Or Givol
Abdulla Watad
Asaf Shemer
Alexander Volkov
Iris Barshack
Mati Fridkin
Miri Blank
Yehuda Shoenfeld
Omry Koren
author_facet Hadar Neuman
Hadar Mor
Tomer Bashi
Or Givol
Abdulla Watad
Asaf Shemer
Alexander Volkov
Iris Barshack
Mati Fridkin
Miri Blank
Yehuda Shoenfeld
Omry Koren
author_sort Hadar Neuman
title Helminth-Based Product and the Microbiome of Mice with Lupus
title_short Helminth-Based Product and the Microbiome of Mice with Lupus
title_full Helminth-Based Product and the Microbiome of Mice with Lupus
title_fullStr Helminth-Based Product and the Microbiome of Mice with Lupus
title_full_unstemmed Helminth-Based Product and the Microbiome of Mice with Lupus
title_sort helminth-based product and the microbiome of mice with lupus
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/d59cf3085af04671b14056e5a2b00d22
work_keys_str_mv AT hadarneuman helminthbasedproductandthemicrobiomeofmicewithlupus
AT hadarmor helminthbasedproductandthemicrobiomeofmicewithlupus
AT tomerbashi helminthbasedproductandthemicrobiomeofmicewithlupus
AT orgivol helminthbasedproductandthemicrobiomeofmicewithlupus
AT abdullawatad helminthbasedproductandthemicrobiomeofmicewithlupus
AT asafshemer helminthbasedproductandthemicrobiomeofmicewithlupus
AT alexandervolkov helminthbasedproductandthemicrobiomeofmicewithlupus
AT irisbarshack helminthbasedproductandthemicrobiomeofmicewithlupus
AT matifridkin helminthbasedproductandthemicrobiomeofmicewithlupus
AT miriblank helminthbasedproductandthemicrobiomeofmicewithlupus
AT yehudashoenfeld helminthbasedproductandthemicrobiomeofmicewithlupus
AT omrykoren helminthbasedproductandthemicrobiomeofmicewithlupus
_version_ 1718378363486208000